ArticleAnnals of medicine and surgery (2012)2026
Thyrotoxicosis presenting with periodic paralysis in a young male: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Periodic paralysis is an uncommon presentation of thyrotoxicosis characterized by acute flaccid paralysis due to hypokalemia. Thyrotoxicosis is often missed as the cause of periodic paralysis due to a lack of overt symptoms. Early recognition and appropriate management can prevent recurrent paralysis and fatal complications, such as cardiac arrhythmias. Case presentation: We report a case of a 28 years old male who presented with acute-onset flaccid quadriparesis following a carbohydrate-rich meal. Investigations revealed severe hypokalemia (2.1 mmol/L) and thyrotoxicosis. Thyroid scintigraphy was suggestive of Graves' disease. The patient was managed with cautious potassium supplementation, propranolol, and carbimazole, followed by definitive therapy with radioactive iodine ablation. Clinical discussion: Thyroid hormone stimulates Na⁺/K⁺-ATPase activity, which causes an intracellular potassium shift, resulting in hypokalemia. Periodic paralysis may be seen in a small percentage of patients with thyrotoxicosis and has a predilection for Asian men. Cautious potassium supplementation is recommended, as rapid supplementation can cause rebound hyperkaliemia. The differential diagnosis includes familial hypokalemic periodic paralysis, Guillain-Barré syndrome, and potassium loss from renal or gastrointestinal causes. Conclusion: Thyrotoxicosis should be suspected in patients presenting with hypokalemic periodic paralysis, especially in men of Asian descent. Definitive treatment of the underlying thyroid disorder is essential for the prevention of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.